Strong CK5/6 and P40 expression, commonly seen in squamous cell carcinoma, must be interpreted in conjunction with CD5 positivity to differentiate ITTC from primary squamous cell carcinoma of the thyroid (PSCCT) (45). This evidence concerns the gene CD5 and squamous cell carcinoma.